Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury.
about
The Dark Side of the Force - Constraints and Complications of Cell Therapies for StrokeTherapeutic effects of hMAPC and hMSC transplantation after stroke in miceReview of Preclinical and Clinical Studies of Bone Marrow-Derived Cell Therapies for Intracerebral HemorrhageCXCR4(+)CD45(-) BMMNC subpopulation is superior to unfractionated BMMNCs for protection after ischemic stroke in miceEffects of neural progenitor cells on post-stroke neurological impairment-a detailed and comprehensive analysis of behavioral tests.Current status of cell therapies in stroke.Comparative Therapeutic Effects of Minocycline Treatment and Bone Marrow Mononuclear Cell Transplantation following Striatal Stroke.Differentiation of mouse bone marrow derived stem cells toward microglia-like cells.Molecular and cellular immune responses to ischemic brain injuryAn Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside.Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalopathy.Menstrual blood transplantation for ischemic stroke: Therapeutic mechanisms and practical issues.Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability.Targeting the peripheral inflammatory response to stroke: role of the spleenA transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulationStem cell therapies in preclinical models of stroke associated with agingMechanisms of adhesion and subsequent actions of a haematopoietic stem cell line, HPC-7, in the injured murine intestinal microcirculation in vivo.Humoral activity of cord blood-derived stem/progenitor cells: implications for stem cell-based adjuvant therapy of neurodegenerative disorders.Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke.Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice.Stem Cell-Based Tissue Replacement After Stroke: Factual Necessity or Notorious Fiction?Effectiveness and Safety of Autologous Bone Marrow Stromal Cells Transplantation After Ischemic Stroke: A Meta-AnalysisExtracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic ImmunosuppressionDietary flavonoids are neuroprotective through Nrf2-coordinated induction of endogenous cytoprotective proteins.Hydrogel matrix to support stem cell survival after brain transplantation in stroke.Post-stroke inflammation and the potential efficacy of novel stem cell therapies: focus on amnion epithelial cells.Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.An immunoprotective privilege of corneal epithelial stem cells against Th17 inflammatory stress by producing glial cell-derived neurotrophic factor.Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue.Acute splenic responses in patients with ischemic stroke and intracerebral hemorrhage.The rise of cell therapy trials for stroke: review of published and registered studies.Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities.Bone marrow-derived mononuclear cells do not exert acute neuroprotection after stroke in spontaneously hypertensive rats.Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke.Histological Architecture Underlying Brain-Immune Cell-Cell Interactions and the Cerebral Response to Systemic Inflammation.Progenitor cells as remote "bioreactors": neuroprotection via modulation of the systemic inflammatory response.Cellular replacement and regenerative medicine therapies in ischemic stroke.Cerebroprotective action of angiotensin peptides in stroke.Stem cells for brain repair in neonatal hypoxia-ischemia.Radiopharmaceutical stem cell tracking for neurological diseases.
P2860
Q26800181-68740C2A-5DD4-46E6-A380-2B4425262D29Q27322703-E9E46437-4D9C-4FDB-8F3A-2CDC9667524EQ28079830-97DA9831-9C29-4659-994C-A54A7C319671Q28254272-0835E9AC-5A6C-4E2A-B696-425E1348166CQ30594942-24164EB4-4EDD-4A62-8D57-D62147AC1668Q33614825-2502DD90-B187-4287-BD14-4288330E0E2EQ33872953-3C17FE48-3AD7-4159-8C09-3ECBEDFAF029Q33997746-C43C2D80-EFD0-43E1-B455-0417E8563E71Q34016804-970C7BC2-081E-4048-8327-3A2078A31839Q34107076-68669031-95F2-4458-B770-41943E7CEEE2Q34202309-B40DCCD3-EA57-4FC6-A645-2F3C79C13115Q34253171-1B84C181-2D33-46B8-AFCA-0377FA8F89C1Q34419548-7F494BFF-E3FE-4F0E-9DCD-D7772EBF809CQ34429117-79CAC3D4-F8DF-414C-BC21-97A2FFEF21B4Q34440274-99CE1906-EADA-4EC0-BB90-BA2AC470F7BFQ34442610-D1B02484-DB42-4FA8-808A-7633F84C6EE5Q34648799-959D4EC2-BD49-4703-8E56-6F24B7F24035Q35082645-4D46B218-35A6-4F3C-B0A9-5AF186249596Q35171618-08043162-C8CE-4C90-AC4C-BC9D6FA7D844Q35679579-BCE90DA1-809C-4CF6-B480-E910A71D17B0Q35901180-F9E382A9-4223-4521-9F12-C734DE67953FQ35910972-6C0FBBAC-3FA9-4428-AF08-C9D6BF81895FQ36067866-6F74F2DD-D4CA-41E2-81E5-B6498E88E81CQ36237752-1588E43A-4B37-4C2E-8F39-C8BC9E0FB015Q36419960-D7CD2871-32EB-4A14-B63E-E80A6191DAA0Q36540313-29088EA9-1D55-4E5F-BBE3-E42D1F408908Q36579398-0CF2D0BF-A2DA-47AE-8CAA-4C183DB00CD1Q36625070-55B62905-B7B4-4E01-A050-63006CC29E85Q36971659-E93BACBC-2E2F-446B-A02F-95ABEA445C6BQ37006243-D6546481-5537-4A96-B7CE-813812FB395DQ37025630-FCBDA629-0EDF-4C10-9C95-1A929214A3EDQ37194081-B8378378-FADA-4F82-BCC5-06CF86F36CD3Q37447090-752CDE01-A72B-4C09-8980-D441D10B1D1AQ37536181-B9215E68-5D0B-4C67-B4B5-6A3A66E87FE0Q37592633-2468E66B-5A41-45A4-9033-DA694505DBF3Q37878876-0095C1CE-2D84-4179-A233-3922BB54F7A1Q38010728-7FCDE2F8-0789-4F26-BB3D-87343772533FQ38150360-4B12F9F9-2DB0-43B7-AC1D-3542A0E474A7Q38157667-F233D4C9-FCE0-4B0E-8C9C-A422A8AE078DQ38225145-11752A25-BF4E-45B2-B7D9-DD07AB169102
P2860
Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Hematopoietic stem cells reduc ...... liorate ischemic brain injury.
@en
Hematopoietic stem cells reduc ...... liorate ischemic brain injury.
@nl
type
label
Hematopoietic stem cells reduc ...... liorate ischemic brain injury.
@en
Hematopoietic stem cells reduc ...... liorate ischemic brain injury.
@nl
prefLabel
Hematopoietic stem cells reduc ...... liorate ischemic brain injury.
@en
Hematopoietic stem cells reduc ...... liorate ischemic brain injury.
@nl
P2093
P1433
P1476
Hematopoietic stem cells reduc ...... liorate ischemic brain injury.
@en
P2093
Harald Neumann
Jens Weise
Mathias Bähr
Sönke Schwarting
Wenlin Hao
P304
P356
10.1161/STROKEAHA.108.513978
P407
P50
P577
2008-07-24T00:00:00Z